2[1]Moller J, Hoffman J. Pediatric cardiovascular medicine. A Harcourt Health Sciences Company, 2000. 885
3[2]Paul G, Arthur G. Clinical pediatric arrthythmias. Second Edition. Philadelphia:W.B. Saunders Company, 1999.251
4[4]Robert S, Eve S, Marylou K. Usefulness of clinical factors in predicting outcomes of passive tilt tests in patients with syncope. Am J Cardiol, 2000,85(2):360
5[5]Blair P,Grubb MD.Pathophysiology and differential diagnosis of neurocardiogenic syncope.Am J Cardiol, 1999,84(8A):3Q
6[6]Richard S, Daniel M. Indication, methodology, and classification of results of tilt-table testing. Am J Cardiol,1999,84(8A):10Q
7Massin MM. Neurocardiogenic syncope in children: urrent concepts in diagnosis and management. Pediatr Drugs,2003, 5: 327 -334.
8Lewis DA, Dhala A. Syncope in the pediatric patients. Pediatr Clin North Am, 1999,46:205-219.
9Ammlrall F, Colivicchi F, Santini M. Diagnosing syncope in clinical practice. Implementation of a simplified diagnostic algorithm in a muticentre prospective trial-the OESIL 2 study. Eur Heart J, 2000,21:935-940.
10Massin M, Bomguignont A, Coremans C, et aL Syncope in pediatric patients presenting to an emergency department J Pediatr, 2004,145:223-228.
9Swissa M,Epstein M,Paz O,Shimoni S Caspi A. Head-up tilt table testing in syncope:safety and efficiency of isosorbide versus isoproterenol in pediatric population[J].American Heart Journal,2008,(03):477-482.
10Gieroba ZJ,Newton JL,Parry SW,Norton M Lawson J Kenny RA. Unprovoked and glyceryl trinitrate-ptovoked head-up table test is safe in older people:A review of 10 years'experience[J].Journal of the American Geriatrics Society,2004,(11):1913-1915.doi:10.1111/j.1532-5415.2004.52518.x.
